Impact of a Nurse Navigator on Genomic Testing and Timely Treatment Decision Making in Patients With Breast Cancer
Impact of a Nurse Navigator on Genomic Testing and Timely Treatment Decision Making in Patients With Breast Cancer
复制标题
DOI：
10.1188/15.cjon.510-512
复制
发表时间：
2015-10-01
影响因子：
1.1
通讯作者：
Schmitt, Mary L.
中科院分区：
文献类型：
--
作者：
McAllister, Kelly A.;Schmitt, Mary L.
这一质量改进项目的目的是确定进行基因组检测的适当患者的最佳做法，并提高订购检测和报告结果的及时性。一个由外科医生、放射科医生、内科肿瘤学家和护士组成的跨学科团队一致认为，注册护士导航员将是促进及时获取基因组图谱的关键人物。乍一看，基因组分析已经成为早期乳腺癌患者的标准护理，以帮助制定个性化的治疗计划。护士导航员可以在提高护理及时性方面发挥关键作用。APN-RN模型改善了周转时间，并符合国家综合癌症网络对基因组检测的建议。
The purpose of this quality improvement project was to define best practices for identifying appropriate patients for genomic testing and improve timeliness for ordering tests and reporting results. An interdisciplinary team of surgeons, radiologists, medical oncologists, and nurses agreed that the RN navigator would be the key person to facilitate timely access to genomic profiling.At a GlanceGenomic profiling has become the standard of care for patients with early-stage breast cancer to assist in developing individualized treatment plans.Nurse navigators can play a key role in improving timeliness of care.The APN-RN model led to improvements in turnaround time and complicance with the National Comprehensive Cancer Network's recommendations for genomic testing.